Effects of Whole Body Vibration on Gait Parameters and Postural Control in Children With Down Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A congenital condition known as Down syndrome is typified by an excess of genetic material from chromosome 21, making 47 chromosomes in total. Development of the body and brain may be impacted. About 1 in 700-1100 live births have the condition, and 1 in 700-1100 live births inherit it. Heart disease, hypotonia, ligament laxity, cerebral disabilities, thyroid abnormalities, and metabolic diseases are among the physical, cognitive, and metabolic changes that define it. Reduced performance, increased energy consumption, and altered gait patterns are frequently the results of motor disorders. This study intends to ascertain the effects of whole body vibrations (WBV), an activity that has been recommended for individuals with Down syndrome, on gait parameters and postural control in children with this condition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 12
Healthy Volunteers: f
View:

• Ages 5-12

• Both sexes are chosen

• Children with Down syndrome older than 5 who are more knowledgeable about the exercise to be done are given preference.

Locations
Other Locations
Pakistan
Riphah International University
RECRUITING
Lahore
Contact Information
Primary
Imran Amjad, PhD
Imran.amjad@riphah.edu.pk
9233224390125
Backup
Muhammad Asif Javed, MS
a.javed@riphah.edu.pk
03224209422
Time Frame
Start Date: 2024-10-28
Estimated Completion Date: 2025-03-07
Participants
Target number of participants: 16
Treatments
Experimental: Whole body vibration therapy
Experimental group will receive whole body vibrations while sitting. Walking in all directions,
Other: Routine physical therapy
Group B will be the only one performing routine physical therapy (RPT). Stretching exercises will be part of these regular workouts. Walking in all directions,
Related Therapeutic Areas
Sponsors
Leads: Riphah International University

This content was sourced from clinicaltrials.gov